| RS1346664920 |
MAT1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hepatic methionine adenosyltransferase deficiency, Inborn genetic diseases |
| RS1346688931 |
CDC42BPB
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS1346690922 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 14, CEP290-related ciliopathy |
| RS1346691984 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1346698280 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1346704603 |
TCIRG1
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 1, Autosomal recessive osteopetrosis 1 |
| RS1346705436 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1346707834 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS1346712530 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Diabetes mellitus, permanent neonatal 3 |
| RS1346714219 |
GGCX
|
Health Risk |
Pathogenic |
— |
| RS1346714603 |
MACF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1346716044 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1346719880 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1346732190 |
SNX27
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1346748926 |
INPP5E
|
Health Risk |
Pathogenic |
Joubert syndrome, INPP5E-related disorder |
| RS1346775255 |
MMUT
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency |
| RS1346778409 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1S, Hypertrophic cardiomyopathy 1 |
| RS1346787374 |
GUCA1ANB-GUCA1A;GUCA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone dystrophy 3, Cone dystrophy 3 |
| RS1346819781 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS1346829948 |
ACADS
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of butyryl-CoA dehydrogenase, Deficiency of butyryl-CoA dehydrogenase |
| RS1346842287 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 25 |
| RS1346847201 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS1346882502 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1346929384 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS1346946485 |
ZSWIM6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1346954123 |
ACAT1
|
Health Risk |
Likely pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS1346965647 |
CDHR1
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 15, Retinal dystrophy |
| RS1346974204 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1346976662 |
WDR62
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1346981294 |
FLNC
|
Health Risk |
Likely pathogenic |
Myofibrillar myopathy 5, Hypertrophic cardiomyopathy 26 |
| RS1346981321 |
TSFM
|
Health Risk |
Likely pathogenic |
Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3, Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 |
| RS1347006212 |
ANKRD11
|
Health Risk |
Conflicting classifications of pathogenicity |
KBG syndrome, Inborn genetic diseases |
| RS1347033062 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1347035611 |
MAN2B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1347044526 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS1347050404 |
GLI3
|
Health Risk |
Pathogenic |
— |
| RS1347055289 |
NCSTN
|
Health Risk |
Pathogenic |
Acne inversa, familial |
| RS1347076714 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1347078601 |
TAOK1
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Neurodevelopmental disorder |
| RS1347083065 |
ARL2BP
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1347137461 |
CEACAM16
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 4B, Autosomal dominant nonsyndromic hearing loss 4B |
| RS1347163319 |
INSR
|
Health Risk |
Pathogenic |
— |
| RS1347176614 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1347178549 |
GBA2
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 46, Hereditary spastic paraplegia 46 |
| RS1347205213 |
LSS
|
Health Risk |
Pathogenic |
Alopecia-intellectual disability syndrome 4, Alopecia-intellectual disability syndrome 4 |
| RS1347208359 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1347210621 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS1347223331 |
TRAPPC6B
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with microcephaly, epilepsy |
| RS1347224658 |
NAGLU
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-B |
| RS1347233847 |
ABCC2
|
Health Risk |
Pathogenic |
— |
| RS1347239469 |
SLC12A3
|
Health Risk |
Pathogenic |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS1347261858 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 19, Retinitis pigmentosa |
| RS1347266016 |
MPDZ
|
Health Risk |
Pathogenic |
— |
| RS1347277368 |
SON
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1347285757 |
EEF1D
|
Health Risk |
Likely pathogenic |
Myelodysplastic syndrome associated with isolated del(5q), Myelodysplastic syndrome associated with isolated del(5q) |
| RS1347287232 |
IMPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1347290964 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, ALMS1-related disorder |
| RS1347292940 |
FANCI
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia |
| RS1347299046 |
FOXP2
|
Health Risk |
Pathogenic |
Childhood apraxia of speech, Childhood apraxia of speech |
| RS1347299632 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1347367555 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS1347382107 |
CLCN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS1347387231 |
BCL11B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1347400457 |
MCM3AP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1347407918 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS1347407994 |
TTC8
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 8, Bardet-Biedl syndrome 8 |
| RS1347415564 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS1347416980 |
VHL
|
Health Risk |
Pathogenic/Likely pathogenic |
Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome |
| RS1347418307 |
LTBP3
|
Health Risk |
Pathogenic |
Brachyolmia-amelogenesis imperfecta syndrome, Brachyolmia-amelogenesis imperfecta syndrome |
| RS1347420106 |
POLG2
|
Health Risk |
Pathogenic |
— |
| RS1347421419 |
ALDH7A1
|
Health Risk |
Pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS1347459118 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1347461335 |
IGHMBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronopathy, distal hereditary motor |
| RS1347473020 |
INSR
|
Health Risk |
Conflicting classifications of pathogenicity |
INSR-related disorder, INSR-related disorder |
| RS1347498294 |
MMACHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1347533994 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1347535436 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1347597816 |
TRIM37
|
Health Risk |
Likely pathogenic |
— |
| RS1347601186 |
PRODH
|
Health Risk |
Pathogenic |
Proline dehydrogenase deficiency, Proline dehydrogenase deficiency |
| RS1347618037 |
AP3B2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 48 |
| RS1347629116 |
F8
|
Health Risk |
Pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS1347648325 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS1347651454 |
CBS
|
Health Risk |
Pathogenic |
Homocystinuria, Familial thoracic aortic aneurysm and aortic dissection |
| RS1347662650 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS1347669124 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS1347692516 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS1347694586 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Arrhythmogenic right ventricular dysplasia 10 |
| RS1347697507 |
GRIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS1347701279 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, See cases |
| RS1347714754 |
IQSEC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 1 |
| RS1347724154 |
PAX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1347730847 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1347740802 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Oto-palato-digital syndrome, type II |
| RS1347754955 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS1347758423 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome |
| RS1347764887 |
SIN3A
|
Health Risk |
Likely pathogenic |
SIN3A-related intellectual disability syndrome due to a point mutation, SIN3A-related intellectual disability syndrome due to a point mutation |
| RS1347776232 |
CFTR
|
Health Risk |
Likely pathogenic |
— |
| RS1347798617 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS1347825753 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1347843810 |
DNAH9
|
Health Risk |
Pathogenic |
— |